Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 1
Submit an article Journal homepage
631
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older

Akiko MeguroDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Katsutoshi OzakiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanCorrespondence[email protected]
,
Kazuya SatoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Iekuni OhDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Shinichiro FujiwaraDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Rie HosonumaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Miyuki SasazakiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Yuji KikuchiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Yuji HirataDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Chihiro YamamotoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Mitsuyo UesawaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Hiroyuki KobayashiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Haruko MatsuDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Hiroshi OkabeDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Eisuke UeharaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Akinori NishikawaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Raine TataraDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Kaoru HatanoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Chizuru YamamotoDivision of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan
,
Tomohiro MatsuyamaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Masaki ToshimaDepartment of Infection Prevention and Control, Jichi Medical University, Tochigi, Japan
,
Masuzu UedaDepartment of Clinical Oncology, Jichi Medical University, Tochigi, Japan
,
Ken OhmineDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Takahiro SuzukiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Masaki MoriDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan;Division of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan
,
Tadashi NagaiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
,
Kazuo MuroiDivision of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan
&
Keiya OzawaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
 show all
Pages 43-49 | Received 14 Nov 2010, Accepted 16 Jun 2011, Published online: 24 Aug 2011

References

  • Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med 2010;362: 1417–1429.
  • Alizadeh AA, Eisen MB, Davis RE, . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
  • Rosenwald A, Wright G, Leroy K, . Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003;198:851–862.
  • Savage KJ, Monti S, Kutok JL, . The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003;102:3871–3879.
  • Lenz G, Wright G, Dave SS, . Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008;359:2313–2323.
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987–994.
  • Dixon DO, Neilan B, Jones SE, . Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol 1986;4:295–305.
  • Vose JM, Armitage JO, Weisenburger DD, . The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1988;6:1838–1844.
  • Sehn LH, Berry B, Chhanabhai M, . The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007;109:1857–1861.
  • Lyman GH, Dale DC, Friedberg J, . Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. J Clin Oncol 2004;22:4302–4311.
  • Coiffier B, Lepage E, Briere J, . CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235–242.
  • Feugier P, Van Hoof A, Sebban C, . Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005;23:4117–4126.
  • Pfreundschuh M, Schubert J, Ziepert M, . Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008;9:105–116.
  • Jaffe ES, Harris NL, Vardiman J, . WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
  • Cheson BD, Horning SJ, Coiffier B, . Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244–1253.
  • Cheson BD, Pfistner B, Juweid ME, . Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
  • Delarue R, Tilly H, Salles G, . R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-cell lymphoma: results of the interim analysis of the LNH03-6B GELA study. Blood 2009;114(Suppl. 1): Abstract 406.
  • Gutiérrez A, Mestre F, Pérez-Manga G, . Diffuse large B-cell lymphoma in the older. Crit Rev Oncol Hematol 2011;78:59–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.